Chime in on this | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34441 of 34745  at  7/24/2018 9:28:08 PM  by

egomaniakos


 In response to msg 34438 by  evernewbliss
view thread

Re: Chime in on this

Actually that is a simplification. The premise of a therapeutic index (the ratio of the toxic to therapeutic dose) is that the dose is therapeutic in the first place. In this case it can be argued the dose is not therapeutic.

In this instance ABUS demonstrated that LNP has a higher peak efficacy but shorter duration of action. Sc has a greater effect per mg, however, in a dosing that they thought was clinically usable had a lower peak effect that was more durable.

This also does not equate to everyone therefore using GalNAc. ABUS has been forthright about the comparison in a like per like experiment and expressed that sc is single trigger. It has also not stated that sc will replace LNP. To my, mind a combination may work best.

The fact that ARWR and others are using GalNAc is not isolated from the fact that they have no alternative.

Ego


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 4     Views: 383
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...